Narasimha M Beeraka

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 6

Top Topics

Antimicrobial Resistance

Angiotensin Converting Enzyme

Neural Stem Cells

Cognitive Decline

Top Venues

Reproductive sciences (Thousand Oaks, Calif.)

Stem cell reviews and reports

BioMed research international

This page only lists publications with an associated author ORCID identifier.

Publications

Narasimha M Beeraka, Basappa Basappa, Vladimir N Nikolenko, P A Mahesh
Role of Neurotransmitters in Steady State Hematopoiesis, Aging, and Leukemia. Stem cell reviews and reports (2024)
Jie Yuan, Li Yang, Zhi Li, Hua Zhang, Qun Wang, Bei Wang, Arunachalam Chinnathambi, Chandramohan Govindasamy, Shreeja Basappa, Omantheswara Nagaraja, Mahendra Madegowda, Narasimha M Beeraka, Vladimir N Nikolenko, Minghua Wang, Geng Wang, Kanchugarakoppal S Rangappa, Basappa Basappa
Pyrimidine-triazole-tethered tert-butyl-piperazine-carboxylate suppresses breast cancer by targeting estrogen receptor signaling and β-catenin activation. IUBMB life (2024)
Viktor V Smirnov, Narasimha M Beeraka, Dmitry Yu Butko, Vladimir N Nikolenko, Sergey A Bondarev, Evgeniy E Achkasov, Mikhail Y Sinelnikov, P R Hemanth Vikram
Correction: Updates on Molecular Targets and Epigenetic-Based Therapies for PCOS. Reproductive sciences (Thousand Oaks, Calif.) (2022)
Chinnappa A Uthaiah, Narasimha M Beeraka, Rajalakshmi R, C M Ramya, SubbaRao V Madhunapantula
Role of Neural Stem Cells and Vitamin D Receptor (VDR)-Mediated Cellular Signaling in the Mitigation of Neurological Diseases. Molecular neurobiology 59 (7) (2022)
Viktor V Smirnov, Narasimha M Beeraka, Dmitry Yu Butko, Vladimir N Nikolenko, Sergey A Bondarev, Evgeniy E Achkasov, Mikhail Y Sinelnikov, P R Hemanth Vikram
Updates on Molecular Targets and Epigenetic-Based Therapies for PCOS. Reproductive sciences (Thousand Oaks, Calif.) (2022)
Narasimha M Beeraka, SubbaRao V Tulimilli, Medha Karnik, Surya P Sadhu, Rajeswara Rao Pragada, Gjumrakch Aliev, SubbaRao V Madhunapantula
The Current Status and Challenges in the Development of Vaccines and Drugs against Severe Acute Respiratory Syndrome-Corona Virus-2 (SARS-CoV-2). BioMed research international 2021 (2021)